PRUNE2 and prostate cancer: In experimental models of human prostate cancer, PCA3 overexpression as well as PRUNE2 silencing accelerates the growth of tumor xenografts in vivo, while increasing cell proliferation, adhesion, and migration in vitro (Salameh et al, 2015).